Navigation Links
Marrone Bio Innovations Submits New Bioherbicide for EPA Registration
Date:2/25/2013

Davis, CA (PRWEB) February 25, 2013

Marrone Bio Innovations, Inc. (MBI), a leading global provider of natural pest management products for the agricultural and water treatment markets, announces the submission of a new bioherbicide, MBI-011 EP, to the U. S. Environmental Protection Agency (EPA). This is the second bioherbicide MBI has submitted for approval to the EPA (MBI-005 bioherbicide was EPA-approved in 2012). MBI-011 EP is a post-emergent burndown herbicide that can also be used as a crop desiccant. It has contact activity and no post-application planting restrictions are expected. MBI-011 EP is being submitted for control of annual and perennial grass and broadleaf weeds in the agricultural, non-crop and consumer home and garden markets.

Dr. Phyllis Himmel, MBI vice president of research and development, noted how the product got its start when one of MBI’s chemists screened for herbicidal activity of medicinal herbs. During the testing of 350 different herbs, an extract of dry long pepper (Piper longum L.) fruits showed activity against lettuce seedlings. This active ingredient was identified as sarmentine, a naturally occurring compound that gives black pepper its pungent aroma.

The new bioherbicide offers broad-spectrum control and will provide an alternative to herbicides that are highly prone to resistance. According to the International Survey of Herbicide Resistant Weeds, weeds have developed resistance to 148 different herbicides in 63 crops in 61 countries. “With the continuing and widespread identification of herbicide resistant weeds, we are very excited about submitting this product for registration,” remarks Dr. Pam Marrone, CEO. “It has become increasingly clear that no one product can be the ultimate solution to a weed problem and herbicide users need an array of tools to combat weeds. One of the most important benefits we provide users of all our biopesticide products is helping them strengthen their Integrated Resistance Management (IRM) programs. With our new herbicide, we believe we are making a positive contribution in this area.”

About Marrone Bio Innovations
Marrone Bio Innovations, Inc. is a leading global provider of biopesticides for the agricultural market. Its effective, natural products provide higher crop yields and quality while managing pest resistance and residues. MBI has developed a pipeline of products including several nematicide, fungicide, algaecide and plant health product candidates. The award-winning MBI products for the ag market include Regalia® biofungicide and Grandevo®, a broad-spectrum bioinsecticide. The company recently received EPA approval for Opportune™, a novel bioherbicide and submitted Venerate™, a broad-spectrum contact insecticide discovered through the MBI screening process. MBI currently has more than three dozen patents pending in the U.S. and globally.

Read the full story at http://www.prweb.com/releases/2013/2/prweb10461667.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Marrone Bio Innovations’ Zequanox® Demonstrates Control of Zebra Mussels in Illinois Lake
2. Marrone Bio Innovations’ CEO to Address European Biopesticide Industry at Informa Life Sciences Biopesticides Conference
3. Marrone Bio Innovations Breaks Ground on Michigan Manufacturing Facility
4. Genomic Health Announces Results from Two Studies Demonstrating Innovations in Next Generation Sequencing From Paraffin Tissue, Enhancing Understanding of Tumor Biology
5. Brain Research Foundation 2013 Scientific Innovations Awards To Dr. Jean Hebert and Dr. Brian Litt
6. Prism Awards Honor Innovations in ‘Ubiquitous’ Photonics Technology
7. LATISTA Announces Next-Generation iPad App 2.0 for Construction with Industry Leading Innovations
8. Wake Forest Innovations Partners with Veterinary Bioscience Institute to Develop Educational Programs for Life Science Professionals
9. The Scientist Proudly Announces the Top 10 Innovations of 2012
10. New Report: "Innovations in Drug Delivery - Broad-based Proprietary Technology Platforms to Address Delivery Efficiency and Improve Patient Compliance" Now Available at Twease.org
11. Heartland Plant Innovations Wins Kansas Bioscience Authority Funding
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... , ... February 21, 2017 , ... ... organizations to build connected digital health applications, announced a partnership with Redox, a ... to seamlessly connect to many clinical systems while keeping data secure in the ...
(Date:2/21/2017)... ... February 21, 2017 , ... Genedata, a leading provider ... announced the establishment of Genedata Limited as a new subsidiary in the United ... in life science informatics. Creating the UK subsidiary reinforces Genedata’s commitment to collaborate ...
(Date:2/21/2017)... ... February 21, 2017 , ... The medical potential of stem cells is both ... of medicine, due to their differentiating characteristics. Stem cells are unique as the have ... be induced to become tissue or organic-specific cells with special functions. , Stem ...
(Date:2/21/2017)... ... February 21, 2017 , ... ... manufacturing facility at its headquarters laboratory in Poway, California. Based upon 12 ... of both in-house personnel and consultants, VetStem constructed and validated a state-of-the-art GMP ...
Breaking Biology Technology:
(Date:2/8/2017)...  Aware, Inc. (NASDAQ: AWRE ), a leading ... for its quarter and year ended December 31, 2016. ... $3.9 million compared to $6.9 million in the same quarter ... was $0.6 million compared to $2.6 million in the fourth ... 2016 was $0.5 million, or $0.02 per diluted share, which ...
(Date:2/7/2017)...   MedNet Solutions , an innovative SaaS-based eClinical ... research, is pleased to announce that the latest release ... flexible and award winning eClinical solution, is now available ... is a proven Software-as-a-Service (SaaS) clinical research technology platform ... also delivers an entire suite of eClinical tools to ...
(Date:2/3/2017)... , Feb. 3, 2017  Texas Biomedical Research Institute ... Larry Schlesinger as the Institute,s new President ... Biomed effective May 31, 2017. He is currently the Chair ... of the Center for Microbial Interface Biology at Ohio State ... as the new President and CEO of Texas Biomed," said ...
Breaking Biology News(10 mins):